Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study

• André Maier ,

  Contributed equally to this work with: André Maier, Nikolaus Deigendesch

  Affiliation Department of Neurology, Charité-University Hospital, Campus Virchow-Klinikum, Berlin, Germany

  ⨯
• Nikolaus Deigendesch ,

  Contributed equally to this work with: André Maier, Nikolaus Deigendesch

  Affiliation Max-Planck Institute for Infection Biology, Berlin, Germany

  ⨯
• Kathrin Müller,

  Affiliation Neurology Department, Ulm University, Ulm, Germany

  ⨯
• Jochen H. Weishaupt,

  Affiliation Neurology Department, Ulm University, Ulm, Germany

  ⨯
• Alexander Krannich,

  Affiliation Department of Biostatistics, Coordination Center for Clinical Trials, Charité-University Hospital, Berlin, Germany

  ⨯
• Robert Röhle,

  Affiliation Department of Biostatistics, Coordination Center for Clinical Trials, Charité-University Hospital, Berlin, Germany

  ⨯
• Felix Meissner,

  Affiliation Max-Planck Institute for Infection Biology, Berlin, Germany

  ⨯
• Kaaweh Molawi,

  Affiliation Max-Planck Institute for Infection Biology, Berlin, Germany

  ⨯
• Christoph Münch,

  Affiliation Department of Neurology, Charité-University Hospital, Campus Virchow-Klinikum, Berlin, Germany

  ⨯
• Teresa Holm,

  Affiliation Department of Neurology, Charité-University Hospital, Campus Virchow-Klinikum, Berlin, Germany

  ⨯
• Robert Meyer,

  Affiliation Department of Neurology, Charité-University Hospital, Campus Virchow-Klinikum, Berlin, Germany

  ⨯
• Thomas Meyer ,

  ¶‡ These authors also contributed equally to this work.

  Affiliation Department of Neurology, Charité-University Hospital, Campus Virchow-Klinikum, Berlin, Germany

  ⨯
• Arturo Zychlinsky

  * E-mail: zychlinsky@mpiib-berlin.mpg.de

  ¶‡ These authors also contributed equally to this work.

  Affiliation Max-Planck Institute for Infection Biology, Berlin, Germany

  ⨯